Abstract

Recent advances in high-throughput genotyping and transcript profiling technologies have enabled the inexpensive production of genome-wide dense marker maps in tandem with huge amounts of expression profiles. These large-scale data encompass valuable information about the genetic architecture of important phenotypic traits. Comprehensive models that combine molecular markers and gene transcript levels are increasingly advocated as an effective approach to dissecting the genetic architecture of complex phenotypic traits. The simultaneous utilization of marker and gene expression data to explain the variation in clinical quantitative trait, known as clinical quantitative trait locus (cQTL) mapping, poses challenges that are both conceptual and computational. Nonetheless, the hierarchical Bayesian (HB) modeling approach, in combination with modern computational tools such as Markov chain Monte Carlo (MCMC) simulation techniques, provides much versatility for cQTL analysis. Sillanpää and Noykova (2008) developed a HB model for single-trait cQTL analysis in inbred line cross-data using molecular markers, gene expressions, and marker-gene expression pairs. However, clinical traits generally relate to one another through environmental correlations and/or pleiotropy. A multi-trait approach can improve on the power to detect genetic effects and on their estimation precision. A multi-trait model also provides a framework for examining a number of biologically interesting hypotheses. In this paper we extend the HB cQTL model for inbred line crosses proposed by Sillanpää and Noykova to a multi-trait setting. We illustrate the implementation of our new model with simulated data, and evaluate the multi-trait model performance with regard to its single-trait counterpart. The data simulation process was based on the multi-trait cQTL model, assuming three traits with uncorrelated and correlated cQTL residuals, with the simulated data under uncorrelated cQTL residuals serving as our test set for comparing the performances of the multi-trait and single-trait models. The simulated data under correlated cQTL residuals were essentially used to assess how well our new model can estimate the cQTL residual covariance structure. The model fitting to the data was carried out by MCMC simulation through OpenBUGS. The multi-trait model outperformed its single-trait counterpart in identifying cQTLs, with a consistently lower false discovery rate. Moreover, the covariance matrix of cQTL residuals was typically estimated to an appreciable degree of precision under the multi-trait cQTL model, making our new model a promising approach to addressing a wide range of issues facing the analysis of correlated clinical traits.

Highlights

  • Integrating genetic polymorphism and gene expression data to elucidate the genetic architecture and regulatory networks of complex clinical traits is a rousing trend in modern biology

  • In this paper we extend the hierarchical Bayesian (HB) clinical quantitative trait locus (cQTL) model for inbred line crosses proposed by Sillanpää and Noykova to a multi-trait setting

  • The genomic loci associated with the variation in gene transcript levels, known as expression quantitative trait loci, can be identified through a standard quantitative trait locus (QTL) mapping framework, with transcript levels acting as surrogate for classical quantitative traits (Jansen and Nap, 2001; Schadt et al, 2003; Cheung et al, 2005; Drake et al, 2006; Breitling et al, 2008)

Read more

Summary

Introduction

Integrating genetic polymorphism and gene expression data to elucidate the genetic architecture and regulatory networks of complex clinical traits is a rousing trend in modern biology. Trans eQTLs may aggregate in small segments of DNA sequences called genomic “hotspots” in which each eQTL may regulate a large number of gene transcripts (Breitling et al, 2008; Wu et al, 2008). It is, not straightforward to determine whether an eQTL acts in cis or in trans. Along these lines, Brem et al (2002) used 10 kb as the threshold distance for distinguishing between cis- and trans-regulatory effects

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call